Research progress in molecular pathology markers in medulloblastoma

Medulloblastoma (MB) is the commonest primary malignant brain cancer. The current treatment of MB is usually surgical resection combined with radiotherapy or chemotherapy. Although great progress has been made in the clinical management of MB, tumor metastasis and recurrence are still the main cause...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Zixuan, Zhu, Bingxin, Meng, Qingming, Zhang, Tong, Wu, Yihao, Yu, Rutong, Gao, Shangfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Open Exploration 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017192/
https://www.ncbi.nlm.nih.gov/pubmed/36937322
http://dx.doi.org/10.37349/etat.2023.00126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017192/
https://www.ncbi.nlm.nih.gov/pubmed/36937322
http://dx.doi.org/10.37349/etat.2023.00126

Ejemplares similares